Antidiabetic effect of Tibetan medicine Tang-Kang-Fu-San in db/db mice via activation of PI3K/Akt and AMPK pathways

This study was to investigate the anti-diabetic effects and molecular mechanisms of Tang-Kang-Fu-San (TKFS), a traditional Tibetan medicine, in treating type 2 diabetes mellitus of spontaneous diabetic db/db mice. Firstly HPLC fingerprint analysis was performed to gain the features of the chemical compositions of TKFS. Next different doses of TKFS (0.5 g/kg, 1.0 g/kg, and 2.0 g/kg) were administrated via oral gavage to db/db mice and their controls for 4 weeks. TKFS significantly lowered hyperglycemia and ameliorated insulin resistance (IR) in db/db mice, indicated by results from multiple tests, including fasting blood glucose test, intraperitoneal insulin and glucose tolerance tests, fasting serum insulin levels and homeostasis model assessment of IR analysis as well as histology of pancreas islets. TKFS also decreased concentrations of serum triglyceride, total and low-density lipoprotein cholesterol, even though it did not change the mouse body weights. Results from western blot and immunohistochemistry analysis indicated that TKFS reversed the down-regulation of p-Akt and p-AMPK, and increased the translocation of Glucose transporter type 4 in skeletal muscles of db/db mice. In all, TKFS had promising benefits in maintaining the glucose homeostasis and reducing IR. The underlying molecular mechanisms are related to promote Akt and AMPK activation and Glucose transporter type 4 translocation in skeletal muscles. Our work showed that multicomponent Tibetan medicine TKFS acted synergistically on multiple molecular targets and signaling pathways to treat type 2 diabetes mellitus

A STUDY ON THE SPRINT START IN SHORT-TRACK SPEEDSKATING

INTRODUCTION: To a large extent, the sprint start in the 500-m short-track speed-skating event determines a successful performance. Therefore, it is anticipated that a study on the action in the sprint start would help to improve the outcome of the start. The aim of this study was to perform a kinematic analysis on some important factors that are related to a successful sprint start

JOINT POWER AND ITS RELATIONSHIP TO THE FATIGUE OF HUMAN BODY

In this study, the joint power and its relationship to levels of fatigue in the human body during vertical jumps was examined. The jumping movements, which were performed before and after a 30-second period of pedaling on a Monark bicycle ergometer, were video recorded. The video materials were then analyzed on a motion analysis system. The ground reaction force during jump was measured by a force platform. The joint power was calculated using the data from the above systems. The two groups of data were compared. The variation of joint power at each joint was computed and a quantitative description of the resulting fatigue was obtained

An optimized high-performance liquid chromatography (HPLC) method for benzoylmesaconine determination in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) and its products

<p>Abstract</p> <p>Background</p> <p>Benzoylmesaconine (BMA) is the main <it>Aconitum </it>alkaloid in <it>Radix Aconiti Lateralis Preparata </it>(<it>Fuzi</it>, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation. The present study developed a simple and reliable method using BMA as a marker compound for the quality control of processed aconite roots and their products.</p> <p>Methods</p> <p>After extraction, a high-performance liquid chromatography (HPLC) determination of BMA was conducted on a RP-C₁₈column by gradient elution with acetonitrile and aqueous phase, containing 0.1% phosphoric acid adjusted with triethylamine to pH 3.0.</p> <p>Results</p> <p>A distinct peak profile was obtained and separation of BMA was achieved. Method validation showed that the relative standard deviations (RSDs) of the precision of BMA in all intra-day and inter-day assays were less than 1.36%, and that the average recovery rate was 96.95%. Quantitative analysis of BMA showed that the content of BMA varied significantly in processed aconite roots and their products.</p> <p>Conclusion</p> <p>This HPLC method using BMA as a marker compound is applicable to the quality control of processed aconite roots and their products.</p

A Novel Iron Phosphate Cement Derived from Copper Smelting Slag and its Early Age Hydration Mechanism

Copper slag (CS), a by-product of copper smelting, is normally stockpiled, leading to wastes of resource and space as well as environment pollution. It has not been massively reutilized as a supplementary cementitious material in Portland cement due to its low reactivity. In the present study, CS is for the first time utilized as the base component to prepare an iron phosphate cement (IPC) by reacting with ammonium dihydrogen phosphate (ADP) at room temperature. The influence of the raw materials mass ratio (CS/ADP) on the microstructure and performance of IPC pastes are investigated. It is found that the compressive strength of IPC pastes at all ages is not a monotonic function of CS/ADP, and the paste with CS/ADP of 2.0 gives the highest strengths, i.e., 26.8, 38.9 and 47.5 MPa at 1, 3 and 28 d, respectively. The crystalline phases including FeH2P3O10·H2O and FePO4 are formed as the main reaction products to bind the unreacted CS particles. The early age hydration of IPC is found to be a multi-stage process, involving the initial dissolution of ADP and iron-containing phases of CS, the formation of FeH2P3O10·H2O, the initial generation of FePO4, and the attainment of the hydration reaction equilibrium. Unlike the magnesium phosphate cement, a redox reaction of Fe(Ⅱ) into Fe(Ⅲ) occurs due to the suitable range of pH and oxidation-reduction potential of the IPC system during the hydration reaction

Paeonol ameliorates chronic itch and spinal astrocytic activation via CXCR3 in an experimental dry skin model in mice

Paeonol is a bioactive phenol presents mainly i

Qingpeng Ointment Ameliorates Inflammatory Responses and Dysregulation of Itch-Related Molecules for Its Antipruritic Effects in Experimental Allergic Contact Dermatitis

The pathogenesis of itchy skin diseases including allergic contact dermatitis (ACD) is complicated and the treatment of chronic itch is a worldwide problem. One traditional Tibetan medicine, Qingpeng ointment (QP), has been used in treatment of ACD in China for years. In this study we used HPLC and LC/MS analysis, combined with a BATMAN-TCM platform, for detailed HPLC fingerprint analysis and network pharmacology of QP, and investigated the anti-inflammatory and antipruritic activities of QP on ACD induced by squaric acid dibutylester (SADBE) in mice. The BATMAN-TCM analysis provided information of effector molecules of the main ingredients of QP, and possible chronic dermatitis-associated molecules and cell signaling pathways by QP. In ACD mice, QP treatment suppressed the scratching behavior induced by SADBE in a dose-dependent manner and inhibited the production of Th1/2 cytokines in serum and spleen. Also, QP treatment reversed the upregulation of mRNAs levels of itch-related genes in the skin (TRPV4, TSLP, GRP, and MrgprA3) and DRGs (TRPV1, TRPA1, GRP, and MrgprA3). Furthermore, QP suppressed the phosphorylation of Erk and p38 in the skin. In all, our work indicated that QP can significantly attenuate the pathological alterations of Th1/2 cytokines and itch-related mediators, and inhibit the phosphorylation of MAPKs to treat the chronic itch

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck

<p>Abstract</p> <p>Background</p> <p>Cell cycle deregulation is common in human cancer, and alterations of <it>p27 </it>and <it>p21</it>, two critical cell cycle regulators, have been implicated in the development of many human malignancies. Therefore, we hypothesize that <it>p27 </it>T109G polymorphism individually or in combination with <it>p21 </it>(C98A and C70T) polymorphisms modifies risk of second primary malignancy (SPM) in patients with index squamous cell carcinoma of head and neck (SCCHN).</p> <p>Methods</p> <p>A cohort of 1,292 patients with index SCCHN was recruited between May 1995 and January 2007 at the M.D. Anderson Cancer Center and followed for SPM occurrence. Patients were genotyped for the three polymorphisms. A log-rank test and Cox proportional hazards models were used to compare SPM-free survival and SPM risk.</p> <p>Results</p> <p>We found that patients with <it>p27 </it>109 TG/GG, <it>p21 </it>98 CA/AA and <it>p21 </it>70 CT/TT variant genotypes had a worse SPM-free survival and an increased SPM risk than those with the corresponding <it>p27</it>109 TT, <it>p21 </it>98 CC, and <it>p21 </it>70 CC common genotypes, respectively. After combining the three polymorphisms, there was a trend for significantly increased SPM risk with increasing number of the variant genotypes (<it>P</it>_trend= 0.0002). Moreover, patients with the variant genotypes had an approximately 2.4-fold significantly increased risk for SPM compared with those with no variant genotypes (HR, 2.4, 95% CI, 1.6-3.6).</p> <p>Conclusions</p> <p>These results suggest that <it>p27 </it>T109G polymorphism individually or in combination with <it>p21 </it>(C98A and C70T) polymorphisms increases risk of SPM in patients with index SCCHN.</p